ACDM News Item

Clinical Trials for Medicines – New Notification Scheme

Date: November 27, 2023

The MHRA have recently launched a new notification scheme, the first step in their overhaul of the clinical trials regulations

The notification scheme enables a more streamlined and risk-proportionate approach to processing Clinical Trial Authorisation for “initial” applications.

This new scheme only applies to Clinical Trial Authorisation applications for Phase 4 and certain Phase 3 clinical trials deemed to be of lower risk; it does not include Clinical Trial Authorisation applications for first in human (FIH), Phase 1 or Phase 2, or amendments at this time.

For more information, visit their website here.

You can also watch a video from the MHRA on their LinkedIn here, where Deputy Director of Clinical Investigations and Trials, Andrea Manfrin, explains which trials are eligible for the scheme and the criteria for the trials.

Explore More News

Welcome Veramed as a corporate member

The Association for Clinical Data Management (ACDM) is delighted to welcome Veramed as a . . .

Welcome CROss Alliance as a corporate member

The Association for Clinical Data Management (ACDM) is delighted to welcome CROss Alliance . . .

Regulatory Considerations DMEG Update

With mixed feelings, we share that Silvia Pérez Torres, current chair of the ACDM . . .

Newsletter Committee’s Christmas Copilot Tips

In a time when we are constantly surrounded by artificial intelligence and feel the need . . .

Welcome Data Magik as a corporate member

The Association for Clinical Data Management (ACDM) is delighted to welcome Data Magik as . . .

Welcome The Institute of Cancer Research – Scientific Computing as a corporate member

The Association for Clinical Data Management (ACDM) is delighted to welcome The Institute . . .

Newsletter Committee: Meet Federica

The ACDM is delighted to welcome Federica Migliore of IQVIA to the Newsletter . . .

Welcome P95 as a corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome P95 as a new . . .

AI Symposium Session Summary: Is AI in clinical trials delivering measurable ROI?

At the 4th Annual ACDM Symposium on Artificial Intelligence (AI) in Clinical Trials, the . . .

Newsletter Committee: Meet Neha

The ACDM is delighted to welcome Neha Shah of ITM to the Newsletter Committee. Neha shares . . .

Newsletter Committee: Meet Sylvain

The ACDM is delighted to welcome Sylvain Berthelot of CRScube to the Newsletter . . .

Welcome VHypotenuse as a corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome VHypotenuse as . . .